BRPI0618789A2 - processos de preparação de 5-amino-3h-tiazol [4,5-d] pirimidin-2-ona, de ciclocondensação de 2,4-diamino-5-halo-pirimidina e de oxidação de 5-amino-3h-tiazol [4,5-d] pirimidin-2-tiona - Google Patents

processos de preparação de 5-amino-3h-tiazol [4,5-d] pirimidin-2-ona, de ciclocondensação de 2,4-diamino-5-halo-pirimidina e de oxidação de 5-amino-3h-tiazol [4,5-d] pirimidin-2-tiona

Info

Publication number
BRPI0618789A2
BRPI0618789A2 BRPI0618789A BRPI0618789A BRPI0618789A2 BR PI0618789 A2 BRPI0618789 A2 BR PI0618789A2 BR PI0618789 A BRPI0618789 A BR PI0618789A BR PI0618789 A BRPI0618789 A BR PI0618789A BR PI0618789 A2 BRPI0618789 A2 BR PI0618789A2
Authority
BR
Brazil
Prior art keywords
pyrimidin
amino
thione
thiazol
diamino
Prior art date
Application number
BRPI0618789A
Other languages
English (en)
Inventor
John S Ng
Stephen E Webber
Tingman Wang
Original Assignee
Anadys Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Anadys Pharmaceuticals Inc filed Critical Anadys Pharmaceuticals Inc
Publication of BRPI0618789A2 publication Critical patent/BRPI0618789A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems
BRPI0618789A 2005-11-21 2006-11-20 processos de preparação de 5-amino-3h-tiazol [4,5-d] pirimidin-2-ona, de ciclocondensação de 2,4-diamino-5-halo-pirimidina e de oxidação de 5-amino-3h-tiazol [4,5-d] pirimidin-2-tiona BRPI0618789A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US73805505P 2005-11-21 2005-11-21
PCT/US2006/061111 WO2007062355A2 (en) 2005-11-21 2006-11-20 PROCESS FOR THE PREPARATION OF 5-AMINO-3H- THIAZOLO [4 , 5 -d] PYRIMIDIN- 2 -ONE

Publications (1)

Publication Number Publication Date
BRPI0618789A2 true BRPI0618789A2 (pt) 2016-08-30

Family

ID=37908057

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0618789A BRPI0618789A2 (pt) 2005-11-21 2006-11-20 processos de preparação de 5-amino-3h-tiazol [4,5-d] pirimidin-2-ona, de ciclocondensação de 2,4-diamino-5-halo-pirimidina e de oxidação de 5-amino-3h-tiazol [4,5-d] pirimidin-2-tiona

Country Status (18)

Country Link
US (1) US7781581B2 (pt)
EP (1) EP1973920B1 (pt)
JP (1) JP5117391B2 (pt)
KR (1) KR20080090400A (pt)
CN (1) CN101365705A (pt)
AR (1) AR058210A1 (pt)
AT (1) ATE474842T1 (pt)
AU (1) AU2006318260B2 (pt)
BR (1) BRPI0618789A2 (pt)
CA (1) CA2630463C (pt)
DE (1) DE602006015700D1 (pt)
EA (1) EA200801404A1 (pt)
ES (1) ES2345904T3 (pt)
IL (1) IL191568A0 (pt)
NO (1) NO20082365L (pt)
SG (1) SG152296A1 (pt)
TW (1) TWI383987B (pt)
WO (1) WO2007062355A2 (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI418561B (zh) 2006-06-22 2013-12-11 Anadys Pharmaceuticals Inc ５-胺基-３-（３’-去氧-β-Ｄ-核糖呋喃糖基（ｒｉｂｏｆｕｒａｎｏｓｙｌ））-噻唑并〔４，５-ｄ〕嘧啶-２，７-二酮之前藥
JPWO2012102366A1 (ja) * 2011-01-28 2014-06-30 日本たばこ産業株式会社 新規ピペラジン化合物の製造方法
CN103012284A (zh) * 2012-12-26 2013-04-03 无锡捷化医药科技有限公司 一种2-氨基-5-溴嘧啶类化合物的制备方法
SI3230298T1 (sl) 2014-12-08 2021-04-30 F. Hoffmann-La Roche Ag Spojine 3-substituiranega 5-amino-6H-tiazolo(4,5-d)pirimidin-2,7-diona za zdravljenje ali preprečevanje okužbe z virusom
US11142534B2 (en) 2017-01-06 2021-10-12 Hoffmann-La Roche Inc. Process for the preparation of 3-substituted 5-amino-6H-thiazolo[4,5-d]pyrimidine-2,7-dione compounds
CN111635368B (zh) * 2020-06-12 2021-06-29 东莞市东阳光仿制药研发有限公司 一种胺化合物的制备方法

Family Cites Families (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4539205A (en) 1982-11-09 1985-09-03 Scripps Clinic And Research Foundation Modulation of animal cellular responses with compositions containing 8-substituted guanine derivatives
US4643992A (en) 1982-11-09 1987-02-17 Scripps Clinic And Research Foundation Modulation of animal cellular responses with compositions containing 8-substituted guanine derivatives
US4746651A (en) 1983-11-01 1988-05-24 Scripps Clinic And Research Foundation Antimicrobial chemotherapeutic potentiation using substituted nucleoside derivatives
US5166141A (en) 1983-11-01 1992-11-24 Scripps Clinic And Research Foundation Immunostimulating 7-deaza-7-oxa- and 7-deaza-7-oxo-analogs of 8-substituted-guanine-9-(1'-beta-D-aldoglycosidyl) derivatives and methods of treating test animals
US5011828A (en) 1985-11-15 1991-04-30 Michael Goodman Immunostimulating guanine derivatives, compositions and methods
GB8712745D0 (en) 1987-05-30 1987-07-01 Wellcome Found Antiviral compounds
US5041426A (en) 1987-12-21 1991-08-20 Brigham Young University Immune system enhancing 3-β-d-ribofuranosylthiazolo[4,5-d]pyridimine nucleosides and nucleotides
US4880784A (en) 1987-12-21 1989-11-14 Brigham Young University Antiviral methods utilizing ribofuranosylthiazolo[4,5-d]pyrimdine derivatives
US5041542A (en) 1988-06-03 1991-08-20 Nucleic Acid Research Institute Substituted pyrimido[5,4-d]pyrimidine nucleosides
GB9015914D0 (en) 1990-07-19 1990-09-05 Wellcome Found Heterocyclic compounds
US5248672A (en) 1990-11-01 1993-09-28 The Regents Of The University Of Michigan Polysubstituted benzimidazole nucleosides as antiviral agents
GB9105899D0 (en) 1991-03-20 1991-05-08 Wellcome Found Therapeutic nucleosides
WO1994007904A1 (en) 1992-10-01 1994-04-14 Mcneilab, Inc. Derivatives of 7,8-disubstituted guanosines
GB9301000D0 (en) 1993-01-20 1993-03-10 Glaxo Group Ltd Chemical compounds
US5395937A (en) 1993-01-29 1995-03-07 Minnesota Mining And Manufacturing Company Process for preparing quinoline amines
US5446045A (en) 1993-12-20 1995-08-29 Revankar; Ganapathi R. Antiviral guanine analogs
US5994321A (en) 1993-12-20 1999-11-30 Aronex Pharmaceuticals, Inc. Antiviral guanine analogs
US5496816A (en) * 1994-03-14 1996-03-05 Merck & Co., Inc. Carbapenem antibacterial compounds, compositions containing such compounds and methods of treatment
ES2232871T3 (es) 1996-07-03 2005-06-01 Sumitomo Pharmaceuticals Company, Limited Nuevos derivados de purina.
CA2266889A1 (en) 1996-10-16 1998-04-23 Guangyi Wang Purine l-nucleosides, analogs and uses thereof
US6509320B1 (en) 1996-10-16 2003-01-21 Icn Pharmaceuticals, Inc. Purine L-nucleosides, analogs and uses thereof
US6039969A (en) 1996-10-25 2000-03-21 3M Innovative Properties Company Immune response modifier compounds for treatment of TH2 mediated and related diseases
US6329381B1 (en) 1997-11-28 2001-12-11 Sumitomo Pharmaceuticals Company, Limited Heterocyclic compounds
TW572758B (en) 1997-12-22 2004-01-21 Sumitomo Pharma Type 2 helper T cell-selective immune response inhibitors comprising purine derivatives
AU3213699A (en) * 1998-04-03 1999-10-25 Du Pont Pharmaceuticals Company Thiazolo(4,5-d)pyrimidines and pyridines as corticotropin releasing factor (CRF)antagonists
US6444652B1 (en) 1998-08-10 2002-09-03 Novirio Pharmaceuticals Limited β-L-2'-deoxy-nucleosides for the treatment of hepatitis B
US6545017B1 (en) 2000-12-08 2003-04-08 3M Innovative Properties Company Urea substituted imidazopyridines
US6667312B2 (en) 2000-12-08 2003-12-23 3M Innovative Properties Company Thioether substituted imidazoquinolines
US6664260B2 (en) 2000-12-08 2003-12-16 3M Innovative Properties Company Heterocyclic ether substituted imidazoquinolines
US6545016B1 (en) 2000-12-08 2003-04-08 3M Innovative Properties Company Amide substituted imidazopyridines
US6664264B2 (en) 2000-12-08 2003-12-16 3M Innovative Properties Company Thioether substituted imidazoquinolines
US20020086871A1 (en) 2000-12-29 2002-07-04 O'neill Brian Thomas Pharmaceutical composition for the treatment of CNS and other disorders
CA2444130C (en) 2001-04-17 2010-12-21 Sumitomo Pharmaceuticals Company, Limited Adenine derivatives
US7321033B2 (en) * 2001-11-27 2008-01-22 Anadys Pharmaceuticals, Inc. 3-B-D-ribofuranosylthiazolo [4,5-d] pyrimidine nucleosides and uses thereof
CN101033242A (zh) 2001-11-27 2007-09-12 安那迪斯药品股份有限公司 3－β－呋喃核糖基噻唑并[4，5－d]嘧啶核苷及其应用
MXPA04010983A (es) 2002-05-06 2005-02-14 Genelabs Tech Inc Derivados de nucleosidos para tratar infecciones por el virus de la hepatitis c.
PA8577501A1 (es) * 2002-07-25 2004-02-07 Warner Lambert Co Inhibidores de quinasas
WO2005016235A2 (en) 2003-04-14 2005-02-24 The Regents Of The University Of California Combined use of impdh inhibitors with toll-like receptor agonists
CA2526387A1 (en) * 2003-06-12 2004-12-23 Astellas Pharma Inc. Benzamide derivative or salt thereof
NZ545536A (en) 2003-09-05 2010-04-30 Anadys Pharmaceuticals Inc TLR7 ligands for the treatment of hepatitis C
JP2007527918A (ja) * 2004-03-08 2007-10-04 アムジェン インコーポレイテッド Ｐｐａｒガンマ活性の治療的調節
EP1805156B1 (en) 2004-10-15 2010-12-22 Bayer HealthCare LLC Preparation and use of biphenyl-4-yl-carbonylamino acid derivatives for the treatment of obesity
CN102504001B (zh) * 2004-12-17 2015-02-25 安那迪斯药品股份有限公司 3,5-二取代的和3,5,7-三取代的-3H-噁唑并以及3H-噻唑并[4,5-d]嘧啶-2-酮化合物及其前药
EP1888575A2 (en) 2005-05-09 2008-02-20 Hydra Biosciences, Inc. Compounds for modulating trpv3 function
TWI418561B (zh) 2006-06-22 2013-12-11 Anadys Pharmaceuticals Inc ５-胺基-３-（３’-去氧-β-Ｄ-核糖呋喃糖基（ｒｉｂｏｆｕｒａｎｏｓｙｌ））-噻唑并〔４，５-ｄ〕嘧啶-２，７-二酮之前藥
US7528115B2 (en) 2006-07-18 2009-05-05 Anadys Pharmaceuticals, Inc. Carbonate and carbamate prodrugs of thiazolo[4,5-d]pyrimidines

Also Published As

Publication number Publication date
ATE474842T1 (de) 2010-08-15
AU2006318260A1 (en) 2007-05-31
JP5117391B2 (ja) 2013-01-16
SG152296A1 (en) 2009-05-29
CN101365705A (zh) 2009-02-11
NO20082365L (no) 2008-08-18
CA2630463C (en) 2015-01-06
CA2630463A1 (en) 2007-05-31
EA200801404A1 (ru) 2008-10-30
US7781581B2 (en) 2010-08-24
DE602006015700D1 (de) 2010-09-02
EP1973920B1 (en) 2010-07-21
AR058210A1 (es) 2008-01-23
TW200736265A (en) 2007-10-01
EP1973920A2 (en) 2008-10-01
AU2006318260B2 (en) 2012-05-17
ES2345904T3 (es) 2010-10-05
JP2009516709A (ja) 2009-04-23
WO2007062355A3 (en) 2007-07-26
WO2007062355A2 (en) 2007-05-31
US20070117979A1 (en) 2007-05-24
TWI383987B (zh) 2013-02-01
IL191568A0 (en) 2008-12-29
KR20080090400A (ko) 2008-10-08

Similar Documents

Publication Publication Date Title
AP2378A (en) Sulfonamide derivatives for the treatment of diseases.
AP2359A (en) Sulfonamide derivatives for the treatment of diseases.
NL1030560A1 (nl) Dielektrische vloeistoffen en werkwijzen voor de bereiding daarvan.
WO2005102396A3 (en) Multimodality nanostructures, methods of fabrication thereof, and methods of use thereof
NO20070753L (no) Fremgangsmåte for fremstilling av dihydropteridinoner
NL2000375A1 (nl) Pyrimidinederivaten voor de behandeling van abnormale celgroei.
HK1118556A1 (en) 5-substituted 7-amino-[1,3]thiazolo[4,5-d]pyrimidine derivatives
NL1028599A1 (nl) Verbindingen voor de behandeling van ziekten.
NL1031845A1 (nl) Pyrimidinederivaten voor de behandeling van abnormale celgroei.
WO2007059226A3 (en) Photoactivatable antimicrobial agents
ZA200711105B (en) Novel physiological substance nesfatin substance relevant thereto, and use of the substances
BRPI0618789A2 (pt) processos de preparação de 5-amino-3h-tiazol [4,5-d] pirimidin-2-ona, de ciclocondensação de 2,4-diamino-5-halo-pirimidina e de oxidação de 5-amino-3h-tiazol [4,5-d] pirimidin-2-tiona
DE602005006105D1 (de) Membrankörper und entsprechendes herstellungsverfahren
ITRM20050179A1 (it) Composizione impiegabile per il trattamento delle patologie paradontali.
NL1033562A1 (nl) Tetrahydropyridoazepine-8-onen en verwante verbindingen voor de behandeling van schizofrenie.
FR2889218B1 (fr) Cuvette de w.c. reglable
NO20082458L (no) Fremgangsmåter for fremstilling av cyklopropyl-amidderivat
FI20041642A0 (fi) Jarrukatkoja
ATA3402004A (de) Kunstleder
ES1056745Y (es) Jaula de estructura desechable.
FI20041385A0 (fi) Symmetria-akselin määrittäminen
NL1028597A1 (nl) Formamidederivaten voor de behandeling van ziekten.
ZA200706203B (en) Processes and compounds for the preparation of substituted naphthylindole derivatives
ES1060982Y (es) Boton de emergencia.
NL1026117A1 (nl) Rolstoel.

Legal Events

Date Code Title Description
B06G Technical and formal requirements: other requirements [chapter 6.7 patent gazette]

Free format text: SOLICITA-SE A REGULARIZACAO DA PROCURACAO, UMA VEZ QUE BASEADO NO ARTIGO 216 PAR 1O DA LPI, O DOCUMENTO DE PROCURACAO DEVE SER APRESENTADO NO ORIGINAL, TRASLADO OU FOTOCOPIA AUTENTICADA.

B11Z Dismissal: petition dismissal - article 216, par 2 of industrial property law

Free format text: REFERENTE A PETICAO NO 20080074636/RJ DE 19/05/2008.

B11M Decision cancelled [chapter 11.13 patent gazette]

Free format text: O DESPACHO 11.6.1 ESTA SENDO ANULADO TENDO POR BASE A DETERMINACAO DO DIRETOR DE PATENTES, A QUAL E CALCADA NO PARECER NO 0003-2014 AGU/PGF/PFE/INPI/COOPHI-LBC-1.0.

B06H Technical and formal requirements: requirement cancelled [chapter 6.8 patent gazette]

Free format text: O DESPACHO 6.7 ESTA SENDO ANULADO TENDO POR BASE A DETERMINACAO DO DIRETOR DE PATENTES, A QUAL E CALCADA NO PARECER NO 0003-2014 AGU/PGF/PFE/INPI/COOPHI-LBC-1.0.

B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 6A, 7A, 8A E 9A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2384 DE 13-09-2016 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.